Zealand Pharma A/S (FRA:22Z)

Zealand Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	3,713	4,399	6,778	2,923	1,394	843
Market Cap Growth	-43.03%	-35.10%	131.90%	109.73%	65.25%	-28.39%
Enterprise Value	1,745	2,288	5,596	2,726	1,414	721
Last Close Price	50.74	64.02	96.70	50.50	26.70	18.94
PE Ratio	4.30	5.09	-	-	-	-
PS Ratio	3.01	3.57	806.30	63.55	99.69	57.77
PB Ratio	1.87	2.22	5.87	13.68	12.71	6.76
P/TBV Ratio	1.88	2.22	5.88	13.78	12.71	7.17
P/FCF Ratio	4.27	5.06	-	-	-	-
P/OCF Ratio	4.25	5.03	-	-	-	-
EV/Sales Ratio	1.41	1.86	665.70	59.28	101.16	49.41
EV/EBITDA Ratio	1.88	2.47	-	-	-	-
EV/EBIT Ratio	1.88	2.47	-	-	-	-
EV/FCF Ratio	2.01	2.63	-	-	-	-
Debt / Equity Ratio	0.03	0.03	0.05	0.08	0.64	0.85
Debt / EBITDA Ratio	0.06	0.06	-	-	-	-
Debt / FCF Ratio	0.06	0.06	-	-	-	-
Net Debt / Equity Ratio	-0.99	-0.99	-1.00	-0.95	-0.80	-0.69
Net Debt / EBITDA Ratio	-2.12	-2.12	6.88	2.73	0.90	0.83
Net Debt / FCF Ratio	-2.26	-2.26	9.20	3.47	0.69	0.52
Asset Turnover	0.72	0.72	0.01	0.20	0.06	0.06
Inventory Turnover	-	-	0.85	0.69	-	0.12
Quick Ratio	23.20	23.20	20.85	6.23	6.73	4.80
Current Ratio	23.57	23.57	21.14	6.25	6.73	5.15
Return on Equity (ROE)	55.06%	55.06%	-21.13%	-58.43%	-110.75%	-69.99%
Return on Assets (ROA)	33.97%	33.97%	-13.81%	-19.93%	-28.30%	-25.53%
Return on Invested Capital (ROIC)	-	1401.57%	-294.62%	-465.46%	-363.56%	-402.18%
Return on Capital Employed (ROCE)	45.30%	45.30%	-13.90%	-33.10%	-60.70%	-45.10%
Earnings Yield	23.28%	19.65%	-2.13%	-3.23%	-11.60%	-16.24%
FCF Yield	23.43%	19.78%	-1.86%	-2.01%	-9.20%	-19.68%
Buyback Yield / Dilution	-7.70%	-7.70%	-17.40%	-22.49%	-7.77%	-11.73%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.